Niclosamide

Spectrum of activity:	Gram-negative
Combined with other compounds:	Yes
Institute where first reported:	Department of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada
Year first mentioned:	2018
Highest developmental phase:	Preclinical

Chemical structure(s):
Canonical SMILES:	C1=C(C=C(C(=C1)O)C(=O)NC2=CC=C(C=C2Cl)[N+](=O)[O-])Cl
Isomeric SMILES:	C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O
InChI:	InChI=1S/C13H8Cl2N2O4/c14-7-1-4-12(18)9(5-7)13(19)16-11-3-2-8(17(20)21)6-10(11)15/h1-6,18H,(H,16,19)
InChI Key:	RJMUSRYZPJIFPJ-UHFFFAOYSA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/4477

External links:
Guide to Pharmacology:	niclosamide
Main Source:	https://aac.asm.org/content/63/4/e02574-18
Citation:	https://www.drugbank.ca/drugs/DB06803